Lilly Faces First Week of “Bellwether” Cymbalta Withdrawal Lawsuit

Calling it “Poison,” plaintiff Claudia Herrera testified she would not have taken Eli Lilly’s drug Cymbalta had she known the risks. Lilly hid the risks of withdrawal symptoms such as electric-like “zaps,” anxiety, spasms, and suicidal ideation, Herrera lawsuit claims, alleging that nearly half of users experience withdrawal rather than the 1% Lilly claims.
Eli Lilly faces first U.S. trials over Cymbalta withdrawal (Reuters)

Eli Lilly’s Cymbalta ‘Poison,’ Ex-User Says In Bellwether (Law 360)

Eli Lilly Hid Cymbalta Risks, Jury Told As Bellwether Opens (Law 360)

Lilly faces first trial over claims of Cymbalta withdrawal symptoms (FiercePharma)